Longeveron® to Present at the UBS Virtual Organ Restoration and Cell Therapy Day [Yahoo! Finance]
Longeveron Inc. - Class A Common stock (LGVN)
Company Research
Source: Yahoo! Finance
Fireside chat with Ash Verma, SMID-cap Biotech & Specialty Pharma Analyst, UBS Equity Research: Date: Tuesday, October 15, 2024 Time: 3:00 p.m. – 3:45 p.m. ET To register for the event, please contact your UBS representative. The Longeveron investor presentation is available at the “ Events & Presentations ” section of the Company's website. About Longeveron Inc. Longeveron is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. The Company's lead investigational product is Lomecel-B™, an allogeneic medicinal signaling cell (MSC) therapy product isolated from the bone marrow of young, healthy adult donors. Lomecel-B™ has multiple potential mechanisms of action encompassing pro-vascular, pro-regenerative, anti-inflammatory, and tissue repair and healing effects with broad potential applications across a spectrum of disease areas. Longeveron is currently pursuing three pipeline indications: hypoplastic left heart syndr
Show less
Read more
Impact Snapshot
Event Time:
LGVN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LGVN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LGVN alerts
High impacting Longeveron Inc. - Class A Common stock news events
Weekly update
A roundup of the hottest topics
LGVN
News
- Longeveron to Present at Biotech Showcase 2025 [Yahoo! Finance]Yahoo! Finance
- Longeveron to Present at Biotech Showcase 2025GlobeNewswire
- Longeveron Inc. (NASDAQ: LGVN) was upgraded by analysts at Roth Capital to a "strong-buy" rating.MarketBeat
- Longeveron Inc. (NASDAQ: LGVN) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $10.00 price target on the stock.MarketBeat
- Longeveron to Present at the Emerging Growth Virtual Conference on December 5, 2024GlobeNewswire
LGVN
Earnings
- 11/12/24 - Beat
LGVN
Sec Filings
- 12/4/24 - Form 4
- 11/27/24 - Form 144
- 11/14/24 - Form SC
- LGVN's page on the SEC website